Search

everythinglearnresearchcommunity

for

Search:↓

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Afatinib often causes skin problems that need proactive management.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

A man developed an allergic skin reaction after using brimonidine for rosacea.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Baricitinib was effective in treating both early and late onset alopecia areata.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.